Fiona Bragg
Fiona Bragg
BSc (Hons), MBChB, MRCP, MSc, DPhil, FFPH
Clinical Research Fellow
Fiona Bragg is a Clinical Research Fellow based in the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU).
Fiona studied medicine at the University of St Andrews and the University of Manchester, and trained initially in general medicine. Following this, she undertook specialist training in public health in London, during which time she obtained an MSc in Public Health from the London School of Hygiene and Tropical Medicine, a DPhil in Population Health from the Nuffield Department of Population Health, and Fellowship of the Faculty of Public Health.
After completing her public health specialist training in 2016, Fiona returned to CTSU where her research focuses on the epidemiology of diabetes in diverse populations, including using genomic and metabolomic approaches to gain an understanding of the determinants and consequences, in particular vascular consequences, of diabetes.
Fiona is module co-lead for the Non-Communicable Diseases module of the MSc in Global Health Science and teaches epidemiology on the medical student public health course. She is also an Honorary Clinical Research Fellow at the Oxford Centre for Diabetes, Endocrinology and Metabolism.
Recent publications
-
Tumour occurrence in women with Turner Syndrome; a narrative review and single centre case series
Journal article
Diddhenipothage SADM. et al, (2023), Clinical Endocrinology
-
Diabetes and infectious disease mortality in Mexico City
Journal article
EMBERSON J. et al, (2023), BMJ Open Diabetes Research and Care
-
Association of bullying victimization with suicidal ideation and suicide attempt among school students: A school-based study in Zhejiang Province, China.
Journal article
Wang H. et al, (2022), J Affect Disord
-
Association between frequency of dairy product consumption and hypertension: a cross-sectional study in Zhejiang Province, China.
Journal article
Wang H. et al, (2022), Nutr Metab (Lond), 19
-
Adiposity and NMR-measured lipids, lipoproteins, and metabolic biomarkers among 30,000 Mexican adults
Journal article
EMBERSON J. et al, (2022), Communications Medicine